Biopharma companies are showing signs of recovery as they work through another quarter of deal and funding challenges. On the medtech front, activity remains muted—but there are pockets of positive data.
Biopharma venture activity increased in the second quarter of 2023, even as R&D partnerships declined to their lowest quarterly volume in more than five years.
J.P. Morgan’s biopharma therapeutics and medtech licensing reports explore the movement in each sector, offering insight on industry trends that will shape the back half of 2023. The reports, powered by DealForma, highlight:
Download the full reports to better understand these dealmaking trends.
Can markets climb the wall of worry?
Sep 29, 2023
From government shutdown fears to surging bond yields, there’s plenty for investors to fret about – but there’s also reason for optimism.
Eye on the Market: What Was I Made For: Large language models in the real world
Sep 26, 2023
Real-world use of generative artificial intelligence models are impacting the changing relationship between innovation, productivity and employment. Learn more here.
Market thoughts: Start making sense
Sep 22, 2023
Markets haven’t seemed to make much sense this year. They’re starting to make sense again.
Should you stay stashed in cash?
Sep 22, 2023
With the Fed keeping rates “higher for longer,” cash may be a competitive option right now. But cash comes at a cost, and other assets could offer investors even better opportunities.
September 2023 Fed meeting: Hitting pause on rate hikes
Sep 20, 2023
The Fed announced they are keeping rates as-is, but the possibility of another hike before the end of the year remains.
Gas prices are going up: Should you be worried?
Sep 15, 2023
While risks remain, we think prices could ease in the months ahead. To us, this means the consumer should be okay and inflation should continue to cool over the next year.
August 2023 CPI report: Gas prices drive inflation higher to 3.7%
Sep 14, 2023
A 10.6% spike in gasoline prices contributed to a 0.6% increase in the August Consumer Price Index (CPI). Read on to learn more.
Catalysts through year-end: 5 things to watch for
Sep 08, 2023
From the Fed to risks of reaccelerating inflation and a government shutdown, here are the main catalysts that we think will drive markets.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.